Arrhythmia Research Technology, Inc. Declares Cash Dividend Professional Medicine

Arrhythmia Research Technology, Inc. Declares Cash Dividend

July 21, 2011, 7:17 am

Arrhythmia Research Technology, Inc. (the “Company”) (NYSE Amex: HRT) announced that its Board of Directors declared a semi-annual cash dividend of $0.06 per share. The dividend will be paid to holders of record on August 1, 2011, payable on August 12, 2011.

James E. Rouse, President and CEO, stated, “The Board of Directors of the Company declared a dividend reflecting their continued confidence in the future success of the Company.”

The Company through its wholly-owned subsidiary, Micron Products, Inc., manufactures silver plated and non-silver plated conductive resin sensors and distributes metal snaps used in the manufacture of disposable ECG, EEG, EMS and TENS electrodes. Micron’s MIT division provides end-to-end product life cycle management through a comprehensive portfolio of value-added services such as design, engineering, prototyping, manufacturing, machining, assembly and packaging. MIT manufactures custom injection molded products for medical, electronic, industrial and consumer applications, and provides high end mold design, manufacturing and precision machining for various industries. The Company’s wholly-owned subsidiary, RMDDxUSA Corp. and its Canadian subsidiary, RMDDx Corporation, branded “WirelessDx”, is a development stage organization dedicated to the development and commercialization of medical devices and services, medical information technology, medical diagnostics and remote patient monitoring through wireless, internet and telecommunication technologies. The Company’s products also include a customizable proprietary signal-averaging electrocardiography (SAECG) software used in the detection of potentially lethal heart arrhythmias that is reconfigurable for a variety of hardware platforms.

Professional Medicine